AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionWaterloo Capital, L.P.
Latest Disclosed Ownership21,054 shares
Latest Disclosed Value $ 4,578,945
Waterloo Capital, L.P. reports 6.13% decrease in ownership of 4AB / AbbVie Inc.

On May 12, 2026 - Waterloo Capital, L.P. filed a 13F-HR form disclosing ownership of 21,054 shares of AbbVie Inc. (BG:4AB) valued at $4,578,945 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 22,428 shares of AbbVie Inc.. This represents a change in shares of -6.13% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBVIE INC COM COM 00287Y109 21,054 -1,374 -6.13 4,579 -10.66 0.3215
2026-02-10 2025-12-31 13F ABBVIE INC COM COM 00287Y109 22,428 437 1.99 5,125 0.65 0.3690
2025-11-05 2025-09-30 13F ABBVIE INC COM COM 00287Y109 21,991 1,372 6.65 5,092 33.03 0.3786
2025-08-12 2025-06-30 13F ABBVIE INC COM COM 00287Y109 20,619 2,119 11.45 3,827 -1.26 0.3091
2025-05-12 2025-03-31 13F ABBVIE INC COM COM 00287Y109 18,500 3,125 20.33 3,876 41.87 0.3604
2025-02-13 2024-12-31 13F ABBVIE INC COM COM 00287Y109 15,375 307 2.04 2,732 -8.17 0.2879
2024-11-14 2024-09-30 13F ABBVIE INC COM COM 00287Y109 15,068 4,197 38.61 2,976 59.60 0.3247
2024-08-12 2024-06-30 13F ABBVIE INC COM COM 00287Y109 10,871 -1,366 -11.16 1,865 -16.34 0.2237
2024-05-14 2024-03-31 13F ABBVIE INC COM COM 00287Y109 12,237 95 0.78 2,228 18.45 0.2847
2024-02-13 2023-12-31 13F ABBVIE INC COM COM 00287Y109 12,142 10,333 571.20 1,882 599.26 0.3045
2023-11-14 2023-09-30 13F ABBVIE INC COM COM 00287Y109 1,809 1,809 270 0.0791
2023-08-11 2023-06-30 13F ABBVIE INC COM COM 00287Y109 0 -2,529 -100.00 0 -100.00
2023-05-15 2023-03-31 13F ABBVIE INC COM COM 00287Y109 2,529 2,529 403 0.1246
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.